{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:17:06Z","timestamp":1790223426282,"version":"4.1.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.2215\/cjn.08710814","type":"journal-article","created":{"date-parts":[[2015,5,15]],"date-time":"2015-05-15T22:36:31Z","timestamp":1431729391000},"page":"1041-1049","source":"Crossref","is-referenced-by-count":61,"title":["Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance"],"prefix":"10.2215","volume":"10","author":[{"given":"Bekir","family":"Tanriover","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"MacConmara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burhaneddin","family":"Sandikci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet U. S.","family":"Ayvaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutlu","family":"Mete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetra","family":"Tsapepas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilum","family":"Rajora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prince","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronak","family":"Lakhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher Y.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-19-20230601","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1053\/j.ajkd.2010.04.010","article-title":"KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the care of kidney transplant recipients.","volume":"56","author":"Bia","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R3-19-20230601","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1600-6143.2007.01661.x","article-title":"One-year results with extended-release tacrolimus\/MMF, tacrolimus\/MMF and cyclosporine\/MMF in de novo kidney transplant recipients.","volume":"7","author":"Silva","year":"2007","journal-title":"Am J Transplant"},{"key":"R4-19-20230601","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation.","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"R5-19-20230601","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/ajt.12579","article-title":"OPTN\/SRTR 2012 Annual Data Report: Kidney.","volume":"14","author":"Matas","year":"2014","journal-title":"Am J Transplant"},{"key":"R6-19-20230601","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/tri.12043","article-title":"Selection of induction therapy in kidney transplantation.","volume":"26","author":"Hardinger","year":"2013","journal-title":"Transpl Int"},{"key":"R7-19-20230601","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1034\/j.1600-6143.2002.20612.x","article-title":"Limited dose monoclonal IL-2R antibody induction protocol after primary kidney transplantation.","volume":"2","author":"Ahsan","year":"2002","journal-title":"Am J Transplant"},{"key":"R8-19-20230601","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1399-0012.2009.01127.x","article-title":"A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with thymoglobulin in living-donor kidney transplantation.","volume":"24","author":"Woodle","year":"2010","journal-title":"Clin Transplant"},{"key":"R9-19-20230601","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/TP.0b013e3181ea6788","article-title":"The impact of IL2ra induction therapy in kidney transplantation using tacrolimus- and mycophenolate-based immunosuppression.","volume":"90","author":"Gralla","year":"2010","journal-title":"Transplantation"},{"key":"R10-19-20230601","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1097\/TP.0b013e3181a484d7","article-title":"Early outcomes of thymoglobulin and basiliximab induction in kidney transplantation: Application of statistical approaches to reduce bias in observational comparisons.","volume":"87","author":"Willoughby","year":"2009","journal-title":"Transplantation"},{"key":"R12-19-20230601","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/MLR.0b013e3181c1328f","article-title":"The multiple propensity score as control for bias in the comparison of more than two treatment arms: An introduction from a case study in mental health.","volume":"48","author":"Spreeuwenberg","year":"2010","journal-title":"Med Care"},{"key":"R13-19-20230601","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2307\/2533160","article-title":"Matching using estimated propensity scores: Relating theory to practice.","volume":"52","author":"Rubin","year":"1996","journal-title":"Biometrics"},{"key":"R14-19-20230601","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","article-title":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.","volume":"17","author":"D\u2019Agostino","year":"1998","journal-title":"Stat Med"},{"key":"R15-19-20230601","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/aje\/kwj047","article-title":"Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect.","volume":"163","author":"Kurth","year":"2006","journal-title":"Am J Epidemiol"},{"key":"R16-19-20230601","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1399-0012.2011.01517.x","article-title":"Multivariate analysis of antibody induction therapy and their associated outcomes in live donor kidney transplantation in the recent era.","volume":"26","author":"Emami","year":"2012","journal-title":"Clin Transplant"},{"key":"R17-19-20230601","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1097\/TP.0b013e3181a5e034","article-title":"Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads.","volume":"87","author":"Amico","year":"2009","journal-title":"Transplantation"},{"key":"R18-19-20230601","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1097\/01.tp.0000246311.43634.0a","article-title":"Prediction of crossmatch outcome of highly sensitized patients by single and\/or multiple antigen bead Luminex assay.","volume":"82","author":"Vaidya","year":"2006","journal-title":"Transplantation"},{"key":"R19-19-20230601","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1600-6143.2010.03340.x","article-title":"Calculated PRA: Initial results show benefits for sensitized patients and a reduction in positive crossmatches.","volume":"11","author":"Cecka","year":"2011","journal-title":"Am J Transplant"},{"key":"R20-19-20230601","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1440-1797.2010.01414.x","article-title":"Understanding crossmatch testing in organ transplantation: A case-based guide for the general nephrologist.","volume":"16","author":"Mulley","year":"2011","journal-title":"Nephrology (Carlton"},{"key":"R21-19-20230601","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1097\/00007890-199812270-00043","article-title":"Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatching.","volume":"66","author":"Bryan","year":"1998","journal-title":"Transplantation"},{"key":"R22-19-20230601","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1600-6143.2007.01667.x","article-title":"Pretransplant risk assessment in renal allograft recipients using virtual crossmatching.","volume":"7","author":"Bielmann","year":"2007","journal-title":"Am J Transplant"},{"key":"R23-19-20230601","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1097\/TP.0b013e318191404c","article-title":"A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.","volume":"86","author":"Bingaman","year":"2008","journal-title":"Transplantation"},{"key":"R24-19-20230601","first-page":"CD003897","article-title":"Interleukin 2 receptor antagonists for kidney transplant recipients","volume":"1","author":"Webster","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R25-19-20230601","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1097\/00007890-199912270-00009","article-title":"Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil\u2014a prospective randomized study.","volume":"68","author":"Ahsan","year":"1999","journal-title":"Transplantation"},{"key":"R26-19-20230601","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/00007890-200011150-00015","article-title":"Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection.","volume":"70","author":"Vanrenterghem","year":"2000","journal-title":"Transplantation"},{"key":"R27-19-20230601","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1681\/ASN.V11101910","article-title":"A meta-analysis of immunosuppression withdrawal trials in renal transplantation.","volume":"11","author":"Kasiske","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"R28-19-20230601","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-6143.2007.02057.x","article-title":"A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients.","volume":"8","author":"Vincenti","year":"2008","journal-title":"Am J Transplant"},{"key":"R29-19-20230601","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-6143.2004.00655.x","article-title":"A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus.","volume":"5","author":"Woodle","year":"2005","journal-title":"Am J Transplant"},{"key":"R30-19-20230601","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.transproceed.2006.02.116","article-title":"Acute rejection risk in kidney transplant recipients on steroid-avoidance immunosuppression receiving induction with either antithymocyte globulin or basiliximab.","volume":"38","author":"Heilman","year":"2006","journal-title":"Transplant Proc"},{"key":"R31-19-20230601","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/01.TP.0000441089.39840.66","article-title":"Randomized trial of three induction antibodies in kidney transplantation: Long-term results.","volume":"97","author":"Ciancio","year":"2014","journal-title":"Transplantation"},{"key":"R32-19-20230601","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/SLA.0b013e318187d1da","article-title":"A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.","volume":"248","author":"Woodle","year":"2008","journal-title":"Ann Surg"},{"key":"R33-19-20230601","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/ndt\/gfr374","article-title":"Very early steroid withdrawal or complete avoidance for kidney transplant recipients: A systematic review.","volume":"27","author":"Pascual","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R34-19-20230601","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1009546","article-title":"Alemtuzumab induction in renal transplantation.","volume":"364","author":"Hanaway","year":"2011","journal-title":"N Engl J Med"},{"key":"R35-19-20230601","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/TP.0b013e3181b724a5","article-title":"Alemtuzumab versus interleukin-2 receptor antibodies induction in living donor kidney transplantation.","volume":"88","author":"Sampaio","year":"2009","journal-title":"Transplantation"},{"key":"R36-19-20230601","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1399-0012.2004.00148.x","article-title":"Cost-minimization study comparing Simulect vs. thymoglobulin in renal transplant induction.","volume":"18","author":"Lilliu","year":"2004","journal-title":"Clin Transplant"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201506000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:45:26Z","timestamp":1786369526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201506000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.08710814","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}